← Back to Search

Device

Obese, receives access to exercise phone application for Prediabetes

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Type 2 diabetes BMI> 95th percentile A1c>6.5% Age 14-17 (2 years post menarchal)
Prediabetes Age 14-17 (2 years post menarchal)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month
Awards & highlights

Study Summary

This trial will study how an exercise app & glucose monitor can help teens w/obesity, prediabetes & Type 2 diabetes reach their health goals.

Eligible Conditions
  • Prediabetes
  • Obesity
  • Type 2 Diabetes

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
If you are between 14-17 years old, have type 2 diabetes, and have a high body mass index (BMI) and A1c level above a certain point, you will not be able to participate.
Select...
You are between the ages of 14-17 and have prediabetes, which means your blood sugar is higher than normal but not yet at the level of diabetes.
Select...
You are between 14-17 years old, have started your period at least 2 years ago, and your body mass index (BMI) is very high, above the 95th percentile for your age and gender.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Mass Index
Body mass index
skin fold measurement
+1 more
Secondary outcome measures
IL-6
TNF-alpha

Trial Design

6Treatment groups
Experimental Treatment
Active Control
Group I: Type 2 diabetes, receives access to exercise phone applicationExperimental Treatment1 Intervention
prediabetes receives access to exercise phone application and interval contact by health provider in between clinic visit, receives continuous glucose monitor
Group II: Prediabetes, receives access to exercise phone applicationExperimental Treatment1 Intervention
prediabetes receives access to exercise phone application and interval contact by health provider in between clinic visit, receives continuous glucose monitor
Group III: Obese, receives access to exercise phone applicationExperimental Treatment1 Intervention
obese, receives access to exercise phone application and interval contact by health provider in between clinic visits , receives continuous glucose monitor
Group IV: Obese, no interventionActive Control1 Intervention
obese, receives continuous glucose monitor
Group V: Type 2 diabetes, no interventionActive Control1 Intervention
Type 2 diabetes, receives continuous glucose monitor
Group VI: Prediabetes, no interventionActive Control1 Intervention
prediabetes, receives continuous glucose monitor

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,565 Previous Clinical Trials
2,268,358 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is my profile compatible with the requirements for this medical trial?

"The eligibility requirements for this clinical trial involve type 2 diabetes and being aged between 14 and 17. Approximately 90 candidates are expected to enroll in the study."

Answered by AI

Is it permissible for persons of age 20 or older to join this medical research?

"This clinical trial is only recruiting patients aged 14 to 17. In total, there are 221 medical trials targeting minors and 995 studies with elderly participants."

Answered by AI

Is this research initiative accessible to prospective participants at the moment?

"The clinicaltrials.gov website indicates that this trial is no longer recruiting participants - it was first announced on February 1st, 2023 and has since been edited for the last time on January 31st, 2023. However, 1428 other trials are actively seeking out patient enrollees at this moment in time."

Answered by AI
~0 spots leftby Dec 2025